Considering the infiltration and essential role of CD8+ T cells, we further assumed that, NLGP treatment may enhance DC migration to lymph node to prime CD8+ T cells, which eventually infiltrates tumor parenchyma to kill tumor cells (that serves as one of the prime source for VEGF). Here, CD8A is linked to neoplasm.